Association between leptin gene G-2548A polymorphism with metabolic syndrome

Journal of Research in Medical Sciences

Volumn 18, Issue 8, 2013, Pages 668-673

  Hassanzadeh, Taghi ^a,b   Maleki, Monireh ^b   Saidijam, Massoud ^a   Paoli, Max ^c  

^a HAMADAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b HAMADAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

2548G A polymorphism; Leptin; Metabolic syndrome

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LEPTIN; TRIACYLGLYCEROL;

ADULT; ANTHROPOMETRY; ARTICLE; CASE CONTROL STUDY; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DNA POLYMORPHISM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HUMAN; LEPTIN GENE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84884760275     PISSN: 17351995     EISSN: 17357136     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C, American Heart Association, et al. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/ American Heart Association conference on scientifc issues related to defnition. Circulation 2004;109:433-438.
2. Sookoian S, Pirola CJ. Genetics of the cardiometabolic syndrome: New insights and therapeutic implications. Ther Adv Cardiovasc Dis 2007;1:37-47.
3. Wiedmann S, Fischer M, Koehler M, Neureuther K, Riegger G, Doering A, et al. Genetic variants within the LPIN1 gene, encoding lipin, are infuencing phenotypes of the metabolic syndrome in humans. Diabetes 2008;57:209-217.
4. Wang Z, Nakayama T. Infammation, a link between obesity and cardiovascular disease. Mediators Infamm 2010;2010:535918.
5. Ghasabeh TH, Firoozrai M, Zonouz AE, Radmehr H, Zavarehee A, Paoli M. One common polymorphism of cholesteryl ester transfer protein gene in Iranian subjects with and without primary hypertriglyceridemia. Pak J Biol Sci 2007;10:4224-4229.
6. Vaisi-Raygani A, Rahimi Z, Tavilani H, Pourmotabbed T. Butyrylcholinesterase K variant and the APOE-epsilon 4 allele work in synergy to increase the risk of coronary artery disease especially in diabetic patients. Mol Biol Rep 2010;37:2083-2091.
7. Rahimi Z, Felehgari V, Rahimi M, Mozafari H, Yari K, Vaisi-Raygani A, et al. The frequency of factor V Leiden mutation, ACE gene polymorphism, serum ACE activity and response to ACE inhibitor and angiotensin II receptor antagonist drugs in Iranians type II diabetic patients with microalbuminuria. Mol Biol Rep 2011;38:2117-2123.
8. Ghasabeh TH, Firoozrai M, Zonouz AE, Radmehr H, Zavarehee A, Paoli M. Association between cholesteryl ester transfer protein Taq1B polymorphism with lipid levels in primary hyperlipidemic patients. Eur J Lipid Sci Technol 2008;110:225-231.
9. Hassanzadeh T, Firoozrai M, Zonouz AE, Zavarehee A, Paoli M. Taq1B polymorphism of cholesteryl ester transfer protein (CETP) gene in primary combined hyperlipidaemia. Indian J Med Res 2009;129:293-8.
10. Barkhordari A, Hassanzadeh T, Saidiam M, Esmaeili R, Paoli M. Association between cholestryl ester transfer protein D442G polymorphism on serum lipid levels and CETP activity in hypercholesterolemic patients. TUMJ 2012;69:737-743.
11. Wauters M, Considine RV, Van Gaal LF. Human leptin: From an adipocyte hormone to an endocrine mediator. Eur J Endocrinol 2000;143:293-311.
12. Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 1996;334:292-295.
13. Considine RV. Human leptin: An adipocyte hormone with weight-regulatory and endocrine functions. Semin Vasc Med 2005;5:15-24.
14. Frühbeck G. Intracellular signalling pathways activated by leptin. Biochem J 2006;393:7-20.
15. Ye XW, Xiao M, Ye J, Zhang XY, Xiao J, Feng YL, et al. The polymorphism -2548G/A in leptin and severity of chronic obstructive pulmonary disease. Int J Immunogenet 2011;38:45-50.
16. Mafei M, Halaas J, Ravussin E, Pratley RE, Lee GH, Zhang Y, et al. Leptin levels in human and rodent: Measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med 1995;1:1155-1161.
17. Mammès O, Betoulle D, Aubert R, Giraud V, Tuzet S, Petiet A, et al. Novel polymorphisms in the 5' region of the LEP gene: Association with leptin levels and response to low-calorie diet in human obesity. Diabetes 1998;47:487-489.
18. Mammès O, Betoulle D, Aubert R, Herbeth B, Siest G, Fumeron F. Association of the G-2548A polymorphism in the 5' region of the LEP gene with overweight. Ann Hum Genet 2000;64:391-394.
19. Hofstedt J, Eriksson P, Motagui-Tabar S, Arner P. A polymorphism in the leptin promoter region (-2548 G/A) influences gene expression and adipose tissue secretion of leptin. Horm Metab Res 2002;34:355-359.
20. Le Stunf C, Le Bihan C, Schork NJ, Bougnères P. A common promoter variant of the leptin gene is associated with changes in the relationship between serum leptin and fat mass in obese girls. Diabetes 2000;49:2196-200.
21. Li WD, Reed DR, Lee JH, Xu W, Kilker RL, Sodam BR, et al. Sequence variants in the 5' fanking region of the leptin gene are associated with obesity in women. Ann Hum Genet 1999;63:227-234.
22. Azizi F, Hadaegh F, Khalili D, Esteghamati A, Hosseinpanah F, Delavari A, et al. Appropriate definition of metabolic syndrome among Iranian adults: Report of the Iranian national committee of obesity. Arch Iran Med 2010;13:426-428.
23. Fantuzzi G, Faggioni R. Leptin in the regulation of immunity, inflammation, and hematopoiesis. J Leukoc Biol 2000;68:437-446.
24. Isidori AM, Strollo F, Morè M, Caprio M, Aversa A, Moreti C, et al. Leptin and aging: Correlation with endocrine changes in male and female healthy adult populations of diferent body weights. J Clin Endocrinol Metab 2000;85:1954-1962.
25. Skibola CF, Holly EA, Forrest MS, Hubbard A, Bracci PM, Skibola DR, et al. Body mass index, leptin and leptin receptor polymorphisms, and non-hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev 2004;13:779-786.
26. Hinuy HM, Hirata MH, Forti N, Diament J, Sampaio MF, Armaganian D, et al. Leptin G-2548A promoter polymorphism is associated with increased plasma leptin and BMI in Brazilian women. Arq Bras Endocrinol Metabol 2008;52:611-616.
27. Ben Ali S, Kallel A, Ftouhi B, Sediri Y, Feki M, Slimane H, et al. Association of G-2548A LEP polymorphism with plasma leptin levels in Tunisian obese patients. Clin Biochem 2009;42:584-588.
28. Constantin A, Costache G, Sima AV, Glavce CS, Vladica M, Popov DL. Leptin G-2548A and leptin receptor Q223R gene polymorphisms are not associated with obesity in Romanian subjects. Biochem Biophys Res Commun 2010;391:282-286.
29. Wabitsch M, Jensen PB, Blum WF, Christofersen CT, Englaro P, Heinze E, et al. Insulin and cortisol promote leptin production in cultured human fat cells. Diabetes 1996;45:1435-1438.
30. Frühbeck G, Jebb SA, Prentice AM. Leptin: Physiology and pathophysiology. Clin Physiol 1998;18:399-419.
31. Cascio S, Bartella V, Auriemma A, Johannes GJ, Russo A, Giordano A, et al. Mechanism of leptin expression in breast cancer cells: Role of hypoxia-inducible factor-1alpha. Oncogene 2008;27:540-547.
32. Bartella V, Cascio S, Fiorio E, Auriemma A, Russo A, Surmacz E. Insulin-dependent leptin expression in breast cancer cells. Cancer Res 2008;68:4919-4927.
33. Sakaguchi M, Miyazaki M, Takaishi M, Sakaguchi Y, Makino E, Kataoka N, et al. S100C/A11 is a key mediator of Ca (2+)-induced growth inhibition of human epidermal keratinocytes. J Cell Biol 2003;163:825-835.
34. Terrasi M, Fiorio E, Mercanti A, Koda M, Moncada CA, Sulkowski S, et al. Functional analysis of the -2548G/A leptin gene polymorphism in breast cancer cells. Int J Cancer 2009;125:1038-1044.
35. Tsou JH, Chang KY, Wang WC, Tseng JT, Su WC, Hung LY, et al. Nucleolin regulates c-Jun/Sp1-dependent transcriptional activation of cPLA2alpha in phorbol ester-treated non-small cell lung cancer A549 cells. Nucleic Acids Res 2008;36:217-227.
36. Correia ML, Haynes WG. Leptin, obesity and cardiovascular disease. Curr Opin Nephrol Hypertens 2004;13:215-223.
37. Morse SA, Bravo PE, Morse MC, Reisin E. The heart in obesity-hypertension. Expert Rev Cardiovasc Ther 2005;3:647-658.
38. Beltowski J. Leptin and atherosclerosis. Atherosclerosis 2006;189:47-60.